Blog
Wegovy vs Mounjaro: Which is better for weight loss?
If you’re comparing Wegovy vs Mounjaro for weight loss, you’re not alone. These two prescription injections are now at the centre of many medically supervised weight management plans in the UK, especially for adults with a BMI of 27+ who want effective support without constant in-person appointments.
Both treatments can help with meaningful weight loss, but they aren’t identical. They use different active ingredients, work slightly differently in the body, and vary in dose options, side effects, and cost. That means the “better” option depends less on hype and more on your medical history, goals, budget, and how well you tolerate treatment.
In this review, we’ll look closely at mounjaro vs wegovy, what the evidence says, how each medication works, and what to know if you’re considering switching under professional guidance. We’re focusing on the practical questions UK patients actually ask during online consultations: which works faster, which causes fewer side effects, and whether the extra cost is worth it.
Key Takeaways
- When comparing Wegovy vs Mounjaro, Mounjaro usually delivers greater average weight loss in trials, but the best choice still depends on your health history, tolerance, and budget.
- Wegovy contains semaglutide and targets GLP-1, while Mounjaro contains tirzepatide and targets both GLP-1 and GIP, which may explain its stronger weight-loss results.
- Both treatments are once-weekly prescription injections that need gradual dose increases, medical screening, and ongoing monitoring to work safely and effectively.
- Wegovy vs Mounjaro side effects are similar and commonly include nausea, diarrhoea, constipation, and indigestion, so tolerability can matter more than headline results.
- Switching between Wegovy and Mounjaro may help if side effects, plateaued progress, cost, or supply become issues, but a clinician should always manage the change.
- Neither medicine works as a quick fix, so lasting weight loss usually depends on staying on treatment long enough and combining it with nutrition, activity, and regular clinical support.
Is Mounjaro or Wegovy better for weight loss?
For many people, Mounjaro appears to have an edge over Wegovy for total weight loss. In clinical trials, patients taking tirzepatide, the active ingredient in Mounjaro, generally lost more weight on average than those taking semaglutide, the active ingredient in Wegovy.
That said, “better” isn’t just about the headline number on the scales.
We need to weigh up:
- Overall percentage of body weight lost
- How quickly weight loss happens
- Side-effect profile and tolerability
- Dose escalation and ease of use
- Availability and cost in the UK
- Whether the treatment suits your medical background
For some patients, Wegovy may still be the better fit. It has a longer track record in weight management, and some people simply tolerate semaglutide better than tirzepatide. Others prefer the clinical familiarity of Wegovy, especially if they’ve previously done well on a GLP-1 treatment.
Mounjaro, though, has drawn attention because it targets two hormone pathways rather than one, which may explain why average weight loss has been higher in studies. If we’re looking purely at efficacy, Mounjaro often comes out ahead. But if we’re looking at the full picture, the best option is the one prescribed safely, monitored properly, and used consistently long enough to work.
What do the researchers say?
The research is one of the clearest ways to compare Wegovy vs Mounjaro.
Semaglutide 2.4 mg, marketed as Wegovy for weight management, was studied in the STEP trials. In the well-known STEP 1 trial, adults with overweight or obesity lost around 14.9% of body weight on average over 68 weeks compared with lifestyle support alone.[1]
Tirzepatide, used in Mounjaro, was studied in the SURMOUNT programme. In SURMOUNT-1, adults without diabetes lost up to around 20.9% of body weight at the highest dose over 72 weeks.[2]
That difference is significant. Not just statistically, but in real-world terms. For someone weighing 100 kg, that could mean the difference between losing roughly 15 kg and 21 kg.
What this means in practice
Researchers generally conclude that both medicines are effective, but tirzepatide has shown greater average weight reduction in head-to-head and indirect comparisons. Early comparative data, including SURMOUNT-5 updates reported by Eli Lilly, also point towards stronger weight-loss outcomes for tirzepatide than semaglutide, though individual response still varies.
Important caveats
Clinical trial results don’t guarantee personal results. Outcomes depend on:
- adherence to treatment
- dose escalation
- diet and activity changes
- side effects
- whether someone has insulin resistance, type 2 diabetes, or other conditions
So yes, the researchers lean towards Mounjaro for greater average weight loss. But in clinic-style decision-making, we still have to ask: will this particular patient be able to stay on it comfortably and safely?
References
- Wilding JPH et al. STEP 1 trial, New England Journal of Medicine
- Jastreboff AM et al. SURMOUNT-1 trial, New England Journal of Medicine
How do Wegovy and Mounjaro work for weight loss?
Wegovy and Mounjaro both help with weight loss by affecting appetite, fullness, and calorie intake, but they don’t work in exactly the same way.
Wegovy contains semaglutide, a GLP-1 receptor agonist. It mimics a natural gut hormone involved in appetite regulation. In simple terms, it helps us:
- feel fuller sooner
- stay full for longer
- reduce food cravings
- slow stomach emptying
- eat less overall
Mounjaro contains tirzepatide, which activates GLP-1 and GIP receptors. That dual action is the main reason it’s often described as a step beyond standard GLP-1-only treatment.
In practical terms, Mounjaro may:
- reduce appetite more strongly for some people
- improve fullness signals
- help with metabolic regulation
- support greater average weight loss in trials
Neither medicine is a “fat burner”. They work best when prescribed as part of a broader plan that includes nutrition changes, movement, and regular medical review. And neither is suitable for everyone.
For UK patients using online treatment services, this matters. The convenience of a remote consultation is helpful, but these are still prescription medicines that require screening, dose titration, and monitoring for side effects and contraindications.
What’s the difference between Mounjaro and Wegovy?
The biggest differences between mounjaro vs wegovy come down to ingredient, dose range, and how each treatment is escalated.
Active ingredients
- Wegovy: semaglutide
- Mounjaro: tirzepatide
Semaglutide targets GLP-1 receptors only. Tirzepatide targets GLP-1 and GIP receptors. That extra pathway is one reason Mounjaro has generated so much interest.
Mounjaro vs Wegovy doses:
Here’s a simple comparison:
| Treatment | Active ingredient | Maintenance dose range | Maximum dose |
|---|---|---|---|
| Wegovy | Semaglutide | Typically escalated to 2.4 mg weekly | 2.4 mg |
| Mounjaro | Tirzepatide | May be maintained at several dose levels depending on response | 15 mg |
Wegovy usually follows a set pathway up to 2.4 mg weekly, while Mounjaro can be continued at different maintenance strengths depending on effectiveness and tolerability.
Dosing scheduling
Both medications are once-weekly injections. That’s one reason they fit well with medically supervised online care.
Typical titration looks like this:
| Treatment | Starting dose | Dose increase pattern |
|---|---|---|
| Wegovy | 0.25 mg weekly | Usually increased every 4 weeks until target dose |
| Mounjaro | 2.5 mg weekly | Usually increased every 4 weeks as appropriate |
Although both are weekly injections, the pace and end point of dose escalation can differ. If side effects become difficult, clinicians may slow titration or pause at a lower dose rather than pushing upwards too quickly.
Is Mounjaro better than Wegovy?
In many cases, yes, Mounjaro may be better than Wegovy for weight loss. But that answer needs context.
Mounjaro tends to outperform Wegovy on average weight-loss figures. It may also be particularly appealing for people who have struggled with appetite control even though previous efforts. But “better” can mean different things:
- Better for maximum weight loss? Often Mounjaro.
- Better studied specifically as a weight-loss brand? Wegovy has strong dedicated obesity data and broad recognition.
- Better tolerated? It depends on the person.
- Better value? Depends on UK pricing, supply, and dose.
If someone experiences strong nausea, constipation, reflux, or poor adherence on one medication, the less “powerful” option on paper may actually be the better real-life treatment.
We’d also be cautious about thinking of this as a winner-takes-all comparison. In medically supervised weight care, the best treatment is the one that:
- is clinically appropriate
- is tolerated well enough to continue
- fits the patient’s budget and routine
- leads to sustainable progress over months, not just the first few weeks
So if you’re asking whether Mounjaro is better than Wegovy overall, the short answer is: often yes for average weight loss, but not automatically for every patient.
Can you switch from Mounjaro to Wegovy or Wegovy to Mounjaro?
Yes, it may be possible to switch between them, but only under medical supervision. These aren’t interchangeable in a casual sense. Different active ingredients, dose schedules, and side-effect patterns mean a clinician needs to decide whether switching is appropriate and how to do it safely.
People consider switching for a few common reasons:
- side effects are difficult to manage
- weight loss has plateaued
- supply or availability changes
- cost becomes an issue
- a clinician feels another option may be more suitable
How long do I need to stay on either Mounjaro or Wegovy to lose weight?
Most people need several months to see the full benefit. Early appetite changes can happen within weeks, but meaningful weight loss usually builds over time as doses increase.
Stopping too early is one of the main reasons people feel a treatment “didn’t work”. In reality, they may not have reached an effective maintenance dose or stayed on it long enough.
Mounjaro vs Wegovy: Active ingredients and how they work
- Mounjaro: tirzepatide, acting on GLP-1 and GIP
- Wegovy: semaglutide, acting on GLP-1
That difference matters when switching. We can’t assume the same response, side effects, or appetite suppression.
Mounjaro vs Wegovy: Dosages
Switching doesn’t mean matching doses milligram-for-milligram. A clinician will usually restart at an appropriate introductory strength for the new medication, then re-titrate as needed.
Mounjaro vs Wegovy: How to use
Both are injected once weekly, but the injection devices, available strengths, and escalation plans may differ. Patients need clear instructions, especially when changing products.
Mounjaro vs Wegovy: Effectiveness
A switch may improve results for some people, particularly if one drug has been poorly tolerated or hasn’t delivered enough appetite control. But not everyone loses more weight after switching: sometimes the main benefit is better tolerability and consistency.
Mounjaro vs Wegovy: Costs
When looking at wegovy vs mounjaro cost, UK prices vary by provider, dose, and stock. In many settings, Mounjaro and Wegovy are both premium prescription treatments, but the price gap can change over time.
A simple comparison:
| Factor | Wegovy | Mounjaro |
|---|---|---|
| UK pricing | Varies by provider and dose | Varies by provider and dose |
| Long-term cost | Depends on duration and maintenance plan | Depends on duration and maintenance plan |
| Value question | Strong if tolerated well and effective | Strong if greater weight loss offsets price |
For many patients, cost per kilogram lost matters more than monthly list price.
Mounjaro vs Wegovy: Side effects
When comparing wegovy vs mounjaro side effects, the overlap is substantial. Common side effects for both include:
- nausea
- vomiting
- diarrhoea
- constipation
- indigestion
- reduced appetite
- abdominal discomfort
Mounjaro may cause stronger gastrointestinal symptoms for some people, though others find it surprisingly manageable. Wegovy may feel more predictable to patients already familiar with semaglutide.
More serious risks, while less common, can include gallbladder issues, pancreatitis, dehydration, and worsening of certain pre-existing conditions. That’s why screening and follow-up matter, whether care happens in person or via a regulated online consultation.
Is semaglutide or tirzepatide better for weight loss?
If we strip the brand names away, the question becomes: is semaglutide or tirzepatide better for weight loss?
Based on the current evidence, tirzepatide generally delivers greater average weight loss than semaglutide. That’s the clearest takeaway from the available trial data.
But semaglutide still remains a very effective option. It has helped many people achieve clinically meaningful weight loss, improve waist circumference, and reduce obesity-related risk factors. For some patients, it may be the more practical or better-tolerated choice.
So our bottom line on Wegovy vs Mounjaro is this:
- choose tirzepatide/Mounjaro if maximising average weight-loss potential is the priority and it’s clinically suitable
- choose semaglutide/Wegovy if it better fits your medical profile, tolerance, or treatment plan
- choose neither without proper medical assessment
For UK adults seeking convenient, medically supervised treatment, online consultations can make access simpler, but the decision still needs to be personalised. The right prescription isn’t the one with the loudest headlines. It’s the one that’s safe, sustainable, and realistic for your body and your life.
Frequently Asked Questions
Which is better for weight loss: Wegovy or Mounjaro?
In studies, Mounjaro generally leads to greater average weight loss than Wegovy, largely because tirzepatide acts on both GLP-1 and GIP receptors. However, the better option depends on your medical history, side effects, budget, and whether you can stay on treatment long enough to benefit.
What is the difference between Wegovy and Mounjaro?
The main difference between Wegovy vs Mounjaro is the active ingredient and how each medicine works. Wegovy contains semaglutide and targets GLP-1 only, while Mounjaro contains tirzepatide and targets GLP-1 plus GIP. They also differ in dose ranges, escalation plans, and sometimes tolerability.
How do Wegovy and Mounjaro work for weight loss?
Both medicines help reduce appetite, increase feelings of fullness, and lower overall calorie intake. Wegovy works by mimicking GLP-1, while Mounjaro activates both GLP-1 and GIP pathways. Neither is a fat burner, and both work best alongside nutrition changes, activity, and medical supervision.
Can you switch from Wegovy to Mounjaro or from Mounjaro to Wegovy?
Yes, switching may be possible, but only with clinical guidance. Wegovy and Mounjaro are not directly interchangeable, so doses are not matched milligram-for-milligram. A prescriber will usually restart at a suitable starting dose and adjust gradually based on your response, side effects, and treatment goals.
Which has more side effects, Wegovy or Mounjaro?
Wegovy and Mounjaro have similar common side effects, including nausea, vomiting, diarrhoea, constipation, indigestion, and abdominal discomfort. Some people find Mounjaro causes stronger gastrointestinal symptoms, while others tolerate it well. Individual response varies, so monitoring and dose titration are important for both treatments.
How long do I need to take Wegovy or Mounjaro before seeing weight loss results?
Some people notice appetite changes within the first few weeks, but meaningful weight loss usually takes several months. This is because both Wegovy and Mounjaro are increased gradually to improve tolerability. Stopping early can limit results, especially if you have not yet reached an effective maintenance dose.